Welcome to LookChem.com Sign In|Join Free

CAS

  • or

135144-30-8

Post Buying Request

135144-30-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

135144-30-8 Usage

Type of compound

Synthetic steroid hormone and progestin medication

Uses

a. Treatment of menstrual disorders
b. Treatment of endometriosis
c. Component of hormonal contraception

Chemical relation

Related to progesterone

Activity

Potent progestogenic activity

Function

Regulates menstrual cycle and prevents unwanted pregnancies

Administration

Typically taken orally in the form of a pill

Absorption

Well absorbed by the body

Additional studies

a. Hormone replacement therapy
b. Transgender hormone therapy

Investigated for

Potential use in the treatment of breast cancer

Versatility

Important chemical compound with a variety of medical applications

Check Digit Verification of cas no

The CAS Registry Mumber 135144-30-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,5,1,4 and 4 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 135144-30:
(8*1)+(7*3)+(6*5)+(5*1)+(4*4)+(3*4)+(2*3)+(1*0)=98
98 % 10 = 8
So 135144-30-8 is a valid CAS Registry Number.
InChI:InChI=1/C21H28O2/c1-3-18(22)21-12-5-4-6-14(21)7-8-15-16-9-10-19(23)20(16,2)13-11-17(15)21/h1,6,15-18,22H,4-5,7-13H2,2H3/t15-,16-,17-,18-,20-,21+/m0/s1

135144-30-8Downstream Products

135144-30-8Relevant articles and documents

Synthesis and Biochemical Studies of 16- or 19-Substituted Androst-4-enes as Aromatase Inhibitors

Numazawa, Mitsuteru,Mutsumi, Ayako,Hoshi, Kumiko,Oshibe, Mariko,Ishikawa, Etsushi,Kigawa, Hiroki

, p. 2496 - 2504 (2007/10/02)

Androst-4-en-17-one derivatives and androst-4-en-17β-ol derivatives 3, 5, 10, 12, and 19 were synthesized and tested for their ability to inhibit aromatase in human placental microsomes.All the 17-oxo steroids, except compound 25 and 17,19-diol 3 of this series, were effective competitive inhibitors with apparent Ki's ranging from 170 to 455 nM. 19,19-Difluoro steroid 18 and 19-acetylenic alcohol 25, a weak competitive inhibitor (Ki = 7.75 μM), caused a time-dependent, pseudo-first-order inactivation of aromatase activity with kinact's of 0.0213 and 0.1053 min-1 for compounds 18 and 25, respectively.NADPH and oxygen were required for the time-dependent inactivation, and the substrate, androst-4-ene-3,17-dione, prevented it, but a nucleophile, L-cysteine, did not in each case.The results strongly suggest that aromatase would attack the 19-carbon of steroids 18 and 25.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 135144-30-8